HERON THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.45 USD | -3.92% |
|
-7.20% | +44.12% |
| Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
| Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
Chart calendar Heron Therapeutics, Inc.
867aad5865e2a9.LX_Idi6YzpBhtz8tNmJfwi7ba7xlLbg-9rs9zxvdnUo.WjOgEB3XnNIG9WkcBwAuuGb2PutVHdxHsu5K93Dr6HljK4AMaMuK5FL1Zg~41f150a5625c57549c88d1a553fbcd37
Upcoming events on Heron Therapeutics, Inc.
Past events on Heron Therapeutics, Inc.
| 2024-04-10 11:00 am | Needham Healthcare Conference |
| 2024-03-12 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-12 04:05 pm | Q4 2023 Earnings Release |
| 2023-11-14 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-14 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-18 | Northland Capital Markets Institutional Investor Conference |
| 2023-08-14 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-14 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-07 | Annual General Meeting |
| 2023-05-11 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-04-20 11:45 am | Needham Healthcare Conference |
| 2023-03-23 04:30 pm | Q4 2022 Earnings Call |
| 2023-03-23 04:05 pm | Q4 2022 Earnings Release |
| 2023-03-07 02:10 pm | Cowen Health Care Conference |
| 2022-12-01 10:05 am | Evercore ISI HealthCONX Conference |
| 2022-11-08 04:30 pm | Q3 2022 Earnings Call |
| 2022-11-07 | Q3 2022 Earnings Release |
| 2022-09-19 08:30 am | APONVIE FDA Approval Call |
| 2022-08-09 08:30 am | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 146 142 2.84% | 88,6 87,4 1.41% | 86,3 91,8 -5.98% | 108 105 2.63% | 127 124 2.8% | 145 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -225 -177 -27.3% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -211 -202 -4.2% | -228 -220 -3.56% | -218 -223 2.12% | -175 -191 8.77% | -111 -124 10.97% | -32,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -205 -197 -4.12% | -227 -224 -1.41% | -221 -225 1.82% | -182 -197 7.6% | -111 -124 11% | -32,3 |
|
Net income Million USD | Released Forecast Spread | -205 -198 -3.67% | -227 -224 -1.41% | -221 -225 1.82% | -182 -197 7.6% | -111 -121 8.42% | -32,3 |
|
EPS USD | Released Forecast Spread | -2,50 -2,40 -4.34% | -2,50 -2,47 -1.33% | -2,24 -2,28 1.9% | -1,67 -1,85 9.63% | -0,80 -0,93 13.67% | -0,21 |
| Announcement Date | 02/03/20 | 24/02/21 | 28/02/22 | 23/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,7 25,8 -19.86% | 23,5 22,6 3.76% | 27,6 24,7 12.08% | 26,6 27,0 -1.49% | 30,0 27,2 10.24% | 29,6 29,7 -0.24% | 31,8 31,7 0.21% | 31,4 31,8 -1.25% | 34,2 31,2 9.66% | 33,0 | 34,5 | 37,0 | 40,5 |
|
EBIT Million USD | Released Forecast Spread | -53,5 -58,1 7.9% | -62,9 -48,4 -30.11% | -49,5 -51,1 3.19% | -41,9 -42,1 0.46% | -20,4 -37,1 45.21% | -33,1 -23,7 -39.77% | -42,4 -27,8 -52.65% | -24,9 -38,2 34.73% | -10,2 -23,4 56.36% | -10,9 | -8,83 | -7,83 | -4,93 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,6 -58,9 7.15% | -63,9 -48,8 -30.96% | -56,4 -52,4 -7.6% | -41,9 -44,1 5% | -19,9 -36,1 45.03% | -32,8 -24,0 -36.29% | -42,1 -28,3 -48.76% | -25,0 -38,0 34.13% | -10,7 -24,0 55.29% | -10,7 | -8,75 | -7,82 | -5,06 |
|
Net income Million USD | Released Forecast Spread | -54,6 -58,9 7.15% | -63,9 -48,8 -30.96% | -56,4 -52,4 -7.6% | -41,9 -44,1 5% | -19,9 -36,1 45.03% | -32,8 -24,0 -36.29% | -42,1 -28,3 -48.76% | -25,0 -38,0 34.13% | -10,7 -24,0 55.29% | -10,7 | -8,75 | -7,82 | -5,06 |
|
EPS USD | Released Forecast Spread | -0,54 -0,58 6.25% | -0,63 -0,48 -32.35% | -0,55 -0,50 -9.13% | -0,38 -0,38 -1.06% | -0,17 -0,32 46.2% | -0,27 -0,20 -33.33% | -0,35 -0,23 -49.57% | -0,17 -0,31 45.74% | -0,07 -0,16 57.14% | -0,07 | -0,06 | -0,05 | -0,03 |
| Announcement Date | 28/02/22 | 09/05/22 | 09/08/22 | 08/11/22 | 23/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 12/03/24 | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Heron Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HRTX Stock
- Calendar Heron Therapeutics, Inc.
